ENT Today: Preparing yourself and your practice for a surge of COVID patients
UC physician discusses differences between COVID and other respiratory infections
Discerning the difference between COVID-19 symptoms and indications of regular sinus or upper respiratory tract infections can be challenging for ear, nose and throat specialists since all these diagnosis can involve cough, fever, congestion and mucus production. But the ability to do so will help ENT practices handle the busiest time of the year for this specialty as patients come seeking respiratory relief.
Ahmad R. Sedaghat, MD, PhD, director of the division of rhinology, allergy, and anterior skull base surgery at the University of Cincinnati College of Medicine, told ENT Today that because COVID-19 is a viral infection, patients may experience more severe body aches, lethargy, and fatigue compared to a bacterial sinus infection.
“While sinus infections and upper respiratory tract infections may also cause temporary olfactory dysfunction, the prevalence with which it occurs in COVID-19 patients seems to be much higher, such that sudden anosmia should be a trigger to test for COVID-19,” explained Sedaghat.
Read the full story with ENT Today online.
Learn more about Sedaghat’s latest research.
Featured image of Ahmad Sedaghat, MD, PhD, shown in the UC Gardner Neuroscience Institute. Photo by Colleen Kelley/UC Creative + Brand.
Related Stories
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.
Health care industry is hiring despite a job market that has cooled
April 16, 2026
The US labor market has cooled but the demand for health care workers, expecially skilled nurses, remains strong. Interviews with UC College of Nursing admininstrators Dr. Donna Green and Dr. Lindsay Davis were part of a WCPO segment on health care industry hiring.
AI advances in the liver disease field
April 15, 2026
MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.